The Food and Drug Administration announced on July 21 that a former pharmaceutical executive will direct its drug evaluation center.
Dr. George Tidmarsh, an adjunct professor at Stanford University, will lead the FDA’s Center for Drug Evaluation and Research (CDER), the FDA said in a statement.